Komori
Shimadzu (7701) · InitiativeAdvanced

Expanding Joint Research with Leading Research Institutions, Universities and Companies

First written in FY2017-Q1. 6 of 10 entries say "Advanced", first in FY2017. Latest entry: 2026-05-12.

10entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017 – FY2020AdvancedFY2023 – 2026-05-122016: 220162017: 220172018: 020182019: 020192020: 120202021: 020212022: 120222023: 120232024: 120242025: 120252026: 1
Same theme, other companies
Collaboration Among Global R&D Sites and Joint DevelopmentA theme 39 companies write about · 0 as a headwind · 41 as a tailwind

21 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 39 companies compared. The sentences above are computed from all 39.
Full recordFilings, disclosures and news, newest first
  1. 2026-05-12AdvancedEarnings

    「In terms of development, we established a new site for the North America R&D Center in San Francisco」

    The establishment of a new site in San Francisco was presented as an expansion of the North America R&D Center's organization supporting joint development with external research institutions and customers.
  2. FY2026-H1AdvancedAnnual report

    「The mass spectrometry system jointly developed with customers at the North American R&D Center is gaining traction in the clinical testing market.」

    Regarding joint research and development with external research institutions and customers, the results showed an increase in the use of a mass spectrometry system jointly developed with customers at the North America R&D Center in the clinical testing market.
  3. FY2024AdvancedAnnual report

    「Overseas, the company is advancing initiatives including support for open innovation at universities through SPARQ, a research partnership program with 7 universities in North America; support for research into near-infrared photoimmunotherapy (NIR-PIT) for cancer at the US National Cancer Institute; research and development on extending healthy life expectancy at the University of Washington; and a blood testing project at Singapore General Hospital.」

    Specific research partners and projects were disclosed for joint research and open innovation, including SPARQ with 7 universities in North America, the US National Cancer Institute, the University of Washington and hospitals in Singapore.
  4. FY2023AdvancedAnnual report

    「In January 2023, the Company opened Shimadzu Tokyo Innovation Plaza to strengthen its application development capabilities. Taking advantage of its convenient location near Haneda Airport, it strengthened its research and development structure with the aim of creating new value and resolving social issues through joint research and open innovation with research institutions and customers in Japan and overseas.」

    Regarding joint research and open innovation with external research institutions and customers, the opening of the Shimadzu Tokyo Innovation Plaza and the strengthening of application development capabilities have taken concrete shape.
  5. FY2022ReframedAnnual report

    「We will promote joint development with research partners worldwide and build relationships with strategic and business partners to pursue the strategic implementation of solutions in society.」

    The previous initiative of expanding joint research has developed into building relationships with strategic and business partners responsible for joint development with research partners and social implementation.
  6. FY2020AdvancedAnnual report

    「To promote collaboration with leading universities and research institutions, the Company established the Osaka University-Shimadzu Analytical Innovation Collaborative Research Laboratory with Osaka University to create products and businesses applying comprehensive metabolite analysis, and the Food Functional Analysis Joint Research Laboratory with the National Agriculture and Food Research Organization to analyze functional food components. In China, it established the China Innovation Center and Guangzhou Analysis Center to provide solutions in the expanding environmental monitoring and contract analysis fields, thereby strengthening its open innovation capabilities.」

    Regarding joint research and open innovation, the company has disclosed the opening of specific research facilities with universities and research institutions, an innovation center in China and analysis centers.
  7. FY2017AdvancedAnnual report

    「Establishment of “Innovation Centers” in North America, China and Europe as joint research and development bases with advanced research institutions, universities and companies」

    The expansion of joint research has taken concrete form, with plans to open joint research and development centers in North America, China and Europe.
  8. FY2017-Q3RestatedAnnual report

    「Expansion of joint research with leading research institutions, universities and companies, including universities in North America」

    The policy of expanding research with external institutions, including joint research with universities in North America, has been reiterated, but no new achievement milestones have been presented.
  9. FY2017-Q2RestatedAnnual report

    「Expansion of joint research with leading research institutions, universities and companies, including universities in North America」

    Expansion of joint research continues. Universities in North America are cited as an example, but no achievement milestone is provided.
  10. FY2017-Q1First statedAnnual report

    「Expanding joint research with leading research institutions, universities and companies」

    First appearance of the initiative to expand joint research with external research institutions and other organizations.
Moved together

"¥20 Annual Dividend per Share" moved the same way as this thread, in the same document, in 4 of its 10 moves.

444433★123456
  1. ★This thread
  2. 1¥20 Annual Dividend per Share4×
  3. 2Expanding the aftermarket business4×
  4. 3Investing Management Resources in Fundamental Research and Advanced Products and Businesses with a View to the Future4×
  5. 4Demand Fluctuations in Defense and Commercial Aircraft Equipment and Spare Parts4×
  6. 5Lower Sales and Operating Profit but Higher Ordinary Profit and Net Income Amid Yen Appreciation3×
  7. 6Resolving Social Issues Through External Collaboration and the Use of IoT, AI and Robotics3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Shimadzu's next results are scheduled for 2026-11-06. Read the earnings preview It last moved in the Earnings of 2026-05-12: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Expanding Joint Research with Leading Research Institutions, Universities and Companies | Shimadzu Corporation (7701) | Komori